Mergermarket surveyed 100 senior corporate and private equity executives from U.S. firms that had completed at least one healthcare deal in the past two years.
Here are seven statistics:
1. Move from fee-for-service to bundled/value-based payments: 19 percent
2. End of cost-sharing reduction payments to insurers: 18 percent
3. Repeal of the individual mandate: 16 percent
4. Possibility of new regulation to lower drug prices: 13 percent
5. Reduced Medicaid contributions to states: 13 percent
6. Uncertain future of the ACA: 11 percent
7. Reduced reimbursement on 340B qualified drugs: 10 percent
More articles on benchmarking:
Oversights & challenges in healthcare acquisitions — 11 statistics
5 main drivers of healthcare acquisitions
79% of firms will pursue alliances or JVs in the near future — 8 statistics
